Model
Edge
Ligand Pharmaceuticals Inc
LGND
Filing type
8-K
Filing date
Jul 13, 2026
Updated
Jul 14, 2026 ยท 8:36 AM
Copy reference
Filing
8-K
Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Reg. FD
Exhibits
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Reg. FD
GRAPHIC
Graphic